Siirry sisältöön
HPB-ALL
Kudos
Peripheral blood
Sairaus
Precursor T-cell acute lymphoblastic leukemia
Metastaasikohde
Peripheral blood (systemic T-ALL)
Synonyymit
HPB/ALL, HPBALL, FCCH1018

Asiakirjat

HPB-ALL

Cell line · Tuotenumero 302895

HPB-ALL on ihmisen T-solujen akuutin lymfoblastisen leukemian (T-ALL) esiasteesta peräisin oleva solulinja, joka on perustettu 14-vuotiaan japanilaisen pojan ääreisverestä...

€430.00ilman veroja ja toimituskuluja

Räätälöinti / Suositukset

Varastossa
Lot
Suositeltava (tuorein erä)
  • CoA
1

01Yleistä tietoa

Kuvaus

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Kudos
Peripheral blood
Sairaus
Precursor T-cell acute lymphoblastic leukemia
Metastaasikohde
Peripheral blood (systemic T-ALL)
Sovellukset
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Synonyymit
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Luokittelu

Organismi
Ihminen
Sukupuoli
Mies
Kasvuominaisuudet
Jousitus
Bioturvallisuustaso
1

03Ominaisuudet

Morfologia
Lymphoblast-like
Solutyyppi
T-cell
Kaksinkertaistumisaika
~50 hours

04Tunnisteet

Lähdeviite
HPB-ALL (Cytion catalog number 302895)
NCBI-verotunnus
9606
Cellosaurus
CVCL_1820

05Ilmentyminen ja alttius

Mutaatioprofiili
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Käsittely ja viljely

Viljelyalusta
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Ravintolisät
Supplement the medium with 10% FBS
Dissosiaatioreagenssi
dilution
Soluviljely
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Jakosuhde
1 : 10 split
Kylvötiheys
3-5*10^5/ml
Nesteen uusiminen
Subculture : 2 times/week
Sulatus ja viljely
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Laadunvalvonta ja kryosäilytys

Jäädytysaine
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Säilytysolosuhteet

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Toimitusehdot

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Lahjoittaja

Luovuttajan ikä
14 years
Etnisyys
Japanese

10Tuotetiedot

Koostumustaulukko